Evidence map›Paper›PMID 33230760›Full record

ReviewObesity surgery2021

Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature.

Gabriel Plitzko, Grégoire Schmutz, Dino Kröll, Philipp C Nett, Yves Borbély

Open access · hybridAbstract readReview
In one paragraph

Review in Obesity surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Atypical fundal perforation: a case report.Journal of surgical case reports · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gabriel PlitzkoClinic for Visceral Surgery and Medicine, University Hospital Bern Inselspital, and University of Bern, Freiburgstrasse, CH-3010, Bern, Switzerland.
Grégoire SchmutzClinic for Visceral Surgery and Medicine, University Hospital Bern Inselspital, and University of Bern, Freiburgstrasse, CH-3010, Bern, Switzerland.
Dino KröllClinic for Visceral Surgery and Medicine, University Hospital Bern Inselspital, and University of Bern, Freiburgstrasse, CH-3010, Bern, Switzerland.
Philipp C NettClinic for Visceral Surgery and Medicine, University Hospital Bern Inselspital, and University of Bern, Freiburgstrasse, CH-3010, Bern, Switzerland.
Yves BorbélyClinic for Visceral Surgery and Medicine, University Hospital Bern Inselspital, and University of Bern, Freiburgstrasse, CH-3010, Bern, Switzerland. yves.borbely@insel.ch.ORCID http://orcid.org/0000-0003-1997-0675
University of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication of Helicobacter pylori and secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose.

Indexed as

Gastric BypassObesity, MorbidPeptic UlcerGastrectomyHumansUlcerAnti-inflammatory agentsGastric remnantGastritisGastrostomyHemorrhageMorbid obesityNon-steroidal anti-inflammatory drugsPeptic ulcer perforationRoux-Y gastric bypass

Identifiers

PMID33230760
PMCPMC7921036
OpenAlexW3107836329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.